XBI
$144.32-3.65%
as of close, Oct 16, 2026
☾ AH $144.32 -3.65%
SPDR S&P Biotech ETFETF · Themes
SPDR S&P Biotech ETF total returns by year (including dividends)
As of market close, Oct 16, 2026
SPDR S&P Biotech ETF total returns by year (2007–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $121.93 | $144.32 | 0.1% | +18.5% | |
| 2025 | $90.06 | $121.93 | 0.5% | +35.9% | |
| 2024 | $89.29 | $90.06 | 0.1% | +1.0% | |
| 2023 | $83.00 | $89.29 | 0.0% | +7.6% | |
| 2022 | $111.96 | $83.00 | 0.0% | -25.9% | |
| 2021 | $140.78 | $111.96 | 0.0% | -20.4% | |
| 2020 | $95.11 | $140.78 | 0.3% | +48.3% | |
| 2019 | $71.75 | $95.11 | 0.0% | +32.6% | |
| 2018 | $84.87 | $71.75 | 0.2% | -15.3% | |
| 2017 | $59.19 | $84.87 | 0.4% | +43.8% | |
| 2016 | $70.20 | $59.19 | 0.2% | -15.4% | |
| 2015 | $62.15 | $70.20 | 0.4% | +13.4% | |
| 2014 | $43.40 | $62.15 | 0.6% | +43.8% | |
| 2013 | $29.30 | $43.40 | 0.1% | +48.2% | |
| 2012 | $22.13 | $29.30 | 0.1% | +32.5% | |
| 2011 | $21.03 | $22.13 | 0.0% | +5.3% | |
| 2010 | $17.88 | $21.03 | 0.0% | +17.6% | |
| 2009 | $17.87 | $17.88 | 0.1% | +0.1% | |
| 2008 | $19.79 | $17.87 | 0.3% | -9.3% | |
| 2007 | $15.38 | $19.79 | 0.1% | +28.8% |
- Annualized
- +10.9%
- 2007–2026
- Average year
- +14.3%
- 19 full years
- Best year
- +48.3%
- 2020
- Worst year
- -25.9%
- 2022
- Positive years
- 14/19
- 74% up
Annualized (CAGR)
+10.9%
2007–2026
Average year
+14.3%
19 full years
Best year
+48.3%
2020
Worst year
-25.9%
2022
Positive years
14/19
74% up
Total return by period#
Annual
-40%-20%0%20%40%
2007+29%'07
2008-9.3%
2009+0.14%'09
2010+18%
2011+5.3%'11
2012+32%
2013+48%'13
2014+44%
2015+13%'15
2016-15%
2017+44%'17
2018-15%
2019+33%'19
2020+48%
2021-20%'21
2022-26%
2023+7.6%'23
2024+1.0%
2025+36%'25
2026+18%
Methodology#
Total returns, dividends reinvested, measured on XBI. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is SPDR S&P Biotech ETF's average annual return?
- Since 2007, SPDR S&P Biotech ETF (XBI) has returned about 10.9% a year (the compound annual growth rate) and an average calendar-year return of 14.3%.
- What were SPDR S&P Biotech ETF's best and worst years?
- Over 2007–2026, the best year was 2020 (+48.3%) and the worst was 2022 (-25.9%).
- How often is SPDR S&P Biotech ETF up in a year?
- 14 of the 19 full years since 2007 were positive — about 74% of the time.
More on SPDR S&P Biotech ETF
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100